Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-21-009542
Filing Date
2021-10-19
Accepted
2021-10-19 17:59:21
Documents
2
Period of Report
2021-10-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 2785
2 evanspoa.txt EX-24 3850
  Complete submission text file 0001179110-21-009542.txt   8140
Mailing Address AUXILIUM PHARMACEUTICALS, INC. 160 WEST GERMANTOWN PIKE NORRISTOWN PA 19401
Business Address
Stacey Jennifer Evans (Reporting) CIK: 0001321326 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40654 | Film No.: 211332120

Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 267-225-7416
Context Therapeutics Inc. (Issuer) CIK: 0001842952 (see all company filings)

EIN.: 472566423 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations